IL17A and arthritic joint disease: Similarly to WT mice, butyrate supplementation suppressed arthritis severity and CD4+IL-17+T cell frequency only in AhR-sufficient Mb1cre/+ mice but not in Ahrfl/−Mb1cre/+ mice (Figures 3B and S5A).